Clinical Trial Update: To Compare the Efficacy of a Prophylactic Use of Tenofovir by Duration for the Non-Hodgkin's Lymphoma [Phase 4]

View source ↗

Summary

This clinical trial update notes a Phase 4 study comparing the duration of prophylactic Tenofovir use in patients with Non-Hodgkin lymphoma, including Burkitt l…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Burkitt Lymphoma
• Non-hodgkin Lymphoma

Drugs mentioned

• Tenofovir (Tenofovir)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Non-Hodgkin's Lymphoma, Burkitt's | Phase 4 | Status: UNKNOWN